Condition
Enterobacteriaceae Infections clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Enterobacteriaceae Infections clinical trials that are recruiting, at sites in 5 countries (most in Italy (2), Argentina (1), Canada (1)). 1 was first registered in the last 30 days. By phase: Phase 1/2 (2), Phase 4 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1New in 30 days
- 5Countries
Newest Enterobacteriaceae Infections clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Aztreonam-Avibactam in Immunocompromised Patients with Multidrug-Resistant Infections | — | Buenos Aires, City of Buenos Aires | Recruiting | Oct 22, 2026 |
| Using fecal microbiota transplantation to eliminate drug-resistant bacteria from the gut | Phase 1/2 | Roma | Recruiting | Mar 30, 2023 |
| Using fecal transplantation to eliminate drug-resistant bacteria | Phase 3 | Clichy and 10 other locations | Recruiting | Sep 5, 2021 |
| Using fecal microbiota transplantation to treat antibiotic-resistant infections | Phase 1/2 | Rome | Recruiting | Feb 17, 2021 |
| Comparing two antibiotics for treating bloodstream infections from resistant bacteria | Phase 4 | Calgary, Alberta and 13 other locations | Recruiting | Sep 14, 2018 |
All recruiting trials (5)
-
Aztreonam-Avibactam in Immunocompromised Patients with Multidrug-Resistant Infections
This study tests how well and how safely aztreonam-avibactam works in adults with weakened immune systems who have highly resistant Enterobacterales infections.
-
Using fecal microbiota transplantation to eliminate drug-resistant bacteria from the gut
This study is testing whether a treatment called fecal microbiota transplantation can help people get rid of tough drug-resistant bacteria in their gut.
-
Using fecal transplantation to eliminate drug-resistant bacteria
This study is testing whether using fecal transplants can help adults get rid of harmful drug-resistant bacteria in their gut.
-
Using fecal microbiota transplantation to treat antibiotic-resistant infections
This study is testing whether a treatment using healthy gut bacteria from donors can help people get rid of hard-to-treat infections caused by antibiotic-resistant germs.
-
Comparing two antibiotics for treating bloodstream infections from resistant bacteria
This study is testing if a new antibiotic called piperacillin-tazobactam works as well as meropenem for treating bloodstream infections caused by resistant bacteria in adults.
Related topics
Quick answers
How many Enterobacteriaceae Infections clinical trials are recruiting right now?
5, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in Italy (2 trials), Argentina (1 trial), Canada (1 trial), Israel (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2, Phase 4: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.